Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats
Authors
Keywords
-
Journal
TOXICOLOGY MECHANISMS AND METHODS
Volume 22, Issue 6, Pages 488-498
Publisher
Informa UK Limited
Online
2012-03-29
DOI
10.3109/15376516.2012.678406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
- (2011) Zeydin Acar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
- (2010) Christian Cadeddu et al. AMERICAN HEART JOURNAL
- Lipid-lowering drugs and heart failure: where do we go after the statin trials?
- (2010) Timo E Strandberg CURRENT OPINION IN CARDIOLOGY
- Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy
- (2010) Himanshu Sharma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats
- (2010) Wawaimuli Arozal et al. TOXICOLOGY
- Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
- (2009) A. Riad et al. CANCER RESEARCH
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
- (2009) Masashi Yoshida et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart
- (2008) Filomena de Nigris et al. EUROPEAN JOURNAL OF CANCER
- Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat
- (2008) Ru Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-β1/Smad 7 expression in the spontaneously hypertensive rats
- (2008) Yuansheng Zhai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats
- (2008) Pierre Sicard et al. FREE RADICAL RESEARCH
- Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy
- (2008) Kumudha Ramasubbu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide
- (2006) J Damrot et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started